Skin Lesions and Nevi Prevention
Skin Lesions and Nevi Prevention
There is no way to prevent a mole, a seborrhoeic keratosis or a cyst from forming, and that is not the useful question. What can be done is to know the skin you have, to keep a record of the lesions that are being watched, and to check anything that has changed. The essential observation is change rather than appearance — a lesion that has altered in shape, colour or size over weeks or months is the one that needs to be seen, and it does not have to look alarming for that to be true. Protection from further sun exposure is a sensible habit and it does not alter a lesion that already exists, which is why protecting the skin and monitoring it are two separate activities rather than one.
What can realistically be done
Three things are within a patient’s control, and they are more useful than the ones that are not:
- Know your own baseline. Most of the value of monitoring comes from knowing what is normal for your skin, so that a change is recognised as a change rather than as something that may always have been there.
- Keep a record of anything being watched. A photograph and a written measurement convert a vague impression into a comparison, and they cost almost nothing to obtain.
- Check at the interval that has been recommended, and sooner if something changes. A schedule with a defined trigger for coming back early is what makes observation an active plan rather than an open-ended wait.
Why the goal is stated as monitoring rather than prevention. These lesions arise from the skin a person has, and there is no measure that stops them forming. Saying so plainly leaves the patient with the three things that do work, instead of a recommendation that cannot be followed.
How to check your own skin
A skin check takes a few minutes a month and is mostly a matter of light and access:
- Good light and a mirror, including somewhere you can see your back. Most lesions that are missed are in places a person cannot easily see, which is the practical argument for having the whole surface examined professionally at least once.
- Look for change rather than for anything alarming. The question to ask of each lesion is whether it looks different from the last time, not whether it looks worrying in the abstract.
- Ask someone to check the sites you cannot see. The back, the scalp and the backs of the legs are the usual blind spots, and they are the reason a partner or a family member is often usefully involved.
Why self-checking is useful even when it cannot diagnose. Nobody knows your skin as well as you do, and nobody else will notice a change as quickly. What self-checking cannot do is identify a lesion; what it is very good at is deciding when to arrange for one to be identified.
Photographs, measurements and the review interval
The record is what turns monitoring from an intention into a plan, and three components make it work:
- A photograph taken to a standard. Daylight, a consistent distance and a scale beside the lesion make two images comparable. An image taken casually at home is better than nothing and is not equivalent to one taken to a standard.
- The measured size, written down with the date. A recorded dimension settles what memory cannot: whether a lesion has grown or only appears to have grown.
- A stated review interval and a defined trigger for an earlier visit. Together these mean the plan already contains its own next step, and the patient does not have to decide when to be concerned.
Why the record is described as part of the treatment. For a lesion that is being watched, the record is the intervention. Without it, the same wait is simply uncertainty; with it, the wait is a plan with an endpoint and a stated reason for returning sooner.
Sun exposure: what helps and what it does not do
Protection is worth doing, and the boundaries of what it achieves are equally worth stating:
- It limits further exposure. Avoiding the strongest midday sun, covering the skin and using sunscreen reduce cumulative ultraviolet exposure, and cumulative exposure is one of the factors that influence pigmented lesions.
- It does not change a lesion that already exists. A mole that is being watched is not altered by protecting it from the sun, and no one should expect a lesion to fade or resolve because of sun protection.
- It is not a substitute for having a lesion assessed. The two activities address different things: protection works on future exposure, and assessment settles what an existing lesion is.
Why the limits are stated so explicitly. A patient who believes that sun protection is managing an existing lesion may delay having it assessed. Being clear that it does neither harm nor good to the lesion itself keeps the two activities in their proper places.
What should prompt a review before the scheduled date
Three findings are worth acting on immediately, and everything else can wait for the planned appointment:
- A change in shape, colour or size. Growth, darkening, a border that has become blurred or a surface that has altered are the observations that bring a review forward rather than waiting for it.
- Bleeding, crusting, ulceration or new itching without an injury. A stable benign lesion does not produce these, and they are a reason to be seen.
- A lesion that looks different from the others, or that is new and continuing to grow. Standing out from the patient’s own pattern is a finding in itself, independent of any description it does or does not match.
Why the list is deliberately short. A long list of warnings is one that nobody acts on. Naming three findings, and stating that everything else can be assessed at the scheduled review, is what makes those three carry weight.
What monitoring cannot do
Some claims about monitoring are worth correcting, because believing them leads to poorer decisions:
- Self-checking cannot identify a lesion. It can notice change and prompt an assessment; it cannot establish what a lesion is. The identification comes from examination and, where needed, from the microscope.
- Removing a benign lesion does not reduce any risk. Taking off a mole does not make a person safer. What it does is end the question about that mole, by producing tissue that can be examined.
- Watching a lesion is not the same as leaving it alone. Monitoring with a baseline, a date and defined triggers is a plan; watching a lesion without any of those is postponing an assessment, and the two are not equivalent.
Why the distinctions are drawn here. Each of these beliefs leads in a different direction — to over-treatment on the one hand, or to a false sense of safety on the other. Stating what monitoring does and does not do is what allows a patient to make the decision that fits their own skin.